Adenylosuccinate lyase (ADSL; adenylosuccinase; EC 4.3.2.2) is a cytosolic homotetrameric enzyme of purine metabolism that catalyses two distinct beta-elimination (fumarate-releasing) reactions in the same active site. In de novo purine synthesis it cleaves SAICAR ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate) to AICAR plus fumarate, completing the step 2/2 that converts SAICAR toward IMP; and at the IMP-to-AMP branch it cleaves adenylosuccinate (S-AMP) to AMP plus fumarate. The enzyme therefore contributes to both de novo IMP biosynthesis and de novo AMP biosynthesis. It assembles as a homotetramer in which three subunits contribute residues to each of the four active sites, and can associate with other de novo purine synthesis enzymes in the purinosome. Loss-of-function variants cause adenylosuccinate lyase deficiency (ADSLD), an autosomal-recessive neurodevelopmental disorder marked by psychomotor/mental retardation, epilepsy and autistic features, with accumulation of the dephosphorylated substrates SAICA-riboside and succinyladenosine in body fluids.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0070626
(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: SAICAR-lyase (fumarate-forming) activity, one of the two core catalytic functions of ADSL. This IBA is fully consistent with the human experimental data and the enzyme's role in de novo IMP synthesis.
Reason: This is a core molecular function of ADSL, cleaving SAICAR to AICAR plus fumarate as step 2/2 of the de novo IMP pathway. The phylogenetic inference matches the human IDA (PMID:27590927) and UniProt.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
PMID:19405474
the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate
|
|
GO:0004018
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Adenylosuccinate (S-AMP) lyase (fumarate-forming) activity, the second core catalytic function of ADSL, cleaving S-AMP to AMP plus fumarate at the IMP-to-AMP branch.
Reason: Core molecular function, corroborated by human IDA data (PMID:19405474, PMID:16973378) and UniProt catalytic-activity annotation (EC 4.3.2.2, Rhea RHEA:16853).
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ADSL is a cytosolic enzyme; its active form is a cytosolic tetramer. This localization is supported by IBA, IDA (HPA) and TAS (Reactome).
Reason: Cytosolic localization is well established and consistent across phylogenetic, immunofluorescence and Reactome evidence.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
|
|
GO:0044208
'de novo' AMP biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: ADSL catalyses the final step (S-AMP to AMP) of de novo AMP biosynthesis from IMP. This is a core biological process for the gene.
Reason: The SAMP-to-AMP reaction is AMP-from-IMP step 2/2 of the de novo AMP pathway, as stated in the UniProt PATHWAY annotation. IBA is at the correct level.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
AMP biosynthesis via de novo pathway; AMP
|
|
GO:0003824
catalytic activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: Root-level catalytic activity term from InterPro2GO. Not wrong, but far too general given the two specific lyase activities (GO:0004018, GO:0070626) are already annotated with experimental evidence.
Reason: This is an uninformative parent of the specific molecular functions ADSL is already annotated to. It adds no information beyond the specific lyase terms.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
|
|
GO:0004018
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (ARBA/RHEA:16853) of the S-AMP lyase activity, redundant with and corroborated by the experimental IDA annotations.
Reason: Correct molecular function derived from the EC/Rhea mapping; matches the human experimental data.
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
|
|
GO:0009152
purine ribonucleotide biosynthetic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: General purine ribonucleotide biosynthesis process, correctly capturing ADSL's role in de novo IMP/AMP synthesis, though broader than the specific de novo terms.
Reason: A correct, if general, biological-process parent. ADSL participates in purine ribonucleotide biosynthesis via de novo IMP and AMP synthesis.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
|
|
GO:0001666
response to hypoxia
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Stimulus-response process transferred electronically from a rat ortholog via Ensembl Compara. There is no evidence that human ADSL functions as an effector in the hypoxia response; this is an over-propagated ortholog IEA.
Reason: ADSL is a cytosolic purine-biosynthesis lyase. "Response to hypoxia" is a stimulus-response biological process not supported by any experimental data for ADSL, and is a classic Ensembl-Compara over-propagation from an ortholog.
|
|
GO:0006167
AMP biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: AMP biosynthetic process (general parent of de novo AMP biosynthesis), correctly capturing ADSL's production of AMP from S-AMP.
Reason: ADSL produces AMP as the second step of AMP-from-IMP; this general term is correct and is also supported by the human IDA (PMID:11428554).
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
|
|
GO:0006177
GMP biosynthetic process
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: GMP biosynthesis is not catalysed or supported by ADSL. GMP is produced from IMP by IMP dehydrogenase and GMP synthase; ADSL acts on the AMP branch, not the GMP branch.
Reason: Biochemically incorrect. ADSL has no role in GMP synthesis; this is an erroneous Ensembl-Compara ortholog transfer. The enzyme's reactions (SAICAR to AICAR, and S-AMP to AMP) lie on the IMP and AMP branches only.
|
|
GO:0006189
'de novo' IMP biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: ADSL contributes to de novo IMP biosynthesis via its SAICAR-lyase step (SAICAR to AICAR + fumarate), which is step 2/2 in the conversion of SAICAR toward IMP. Core biological process.
Reason: Correct core process. The UniProt PATHWAY annotation places this SAICAR-lyase reaction within de novo IMP biosynthesis.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
IMP biosynthesis via de novo pathway
|
|
GO:0007584
response to nutrient
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Stimulus-response process transferred electronically from a rat ortholog. No experimental support for human ADSL acting as a nutrient-response effector.
Reason: Over-propagated Ensembl-Compara ortholog IEA; not a supportable molecular role for human ADSL, which is a constitutive purine-biosynthesis enzyme.
|
|
GO:0009060
aerobic respiration
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Aerobic respiration is a mitochondrial process; ADSL is a cytosolic purine-biosynthesis lyase. Fumarate release by ADSL does not constitute participation in aerobic respiration.
Reason: Biologically incorrect over-propagation via Ensembl Compara. ADSL is not part of the respiratory chain or TCA cycle; its product fumarate feeds general metabolism but that does not make ADSL a participant in aerobic respiration.
|
|
GO:0014850
response to muscle activity
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Although ADSL is highly expressed in skeletal muscle and participates in the purine nucleotide cycle there, "response to muscle activity" is a stimulus-response biological process electronically transferred from a rat ortholog, without experimental support for human ADSL as an effector of this response.
Reason: Over-propagated Ensembl-Compara ortholog IEA. Muscle expression does not justify a stimulus-response BP annotation; ADSL's role in muscle is its constitutive purine-cycle catalysis.
|
|
GO:0042594
response to starvation
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: Stimulus-response process transferred electronically from a rat ortholog. No experimental support for human ADSL as a starvation-response effector.
Reason: Over-propagated Ensembl-Compara ortholog IEA, not supportable for human ADSL.
|
|
GO:0042802
identical protein binding
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Self-association is real (ADSL is a homotetramer), but "identical protein binding" is an uninformative molecular-function term compared with the enzyme's catalytic activities and its "protein-containing complex" annotation. This IEA duplicates the IDA below.
Reason: The homotetrameric assembly makes identical-protein binding technically correct, but it is non-core relative to the catalytic MFs. Retain as non-core; the homotetramer is better captured by GO:0032991 and the SUBUNIT annotation.
Supporting Evidence:
PMID:19405474
ASL, a catalyst of key reactions in purine biosynthesis, is normally a homotetramer in which three subunits contribute to each of four active sites
|
|
GO:0044208
'de novo' AMP biosynthetic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation of de novo AMP biosynthesis (UniPathway UPA00075), redundant with the IBA and consistent with the S-AMP-to-AMP reaction.
Reason: Correct core process, matching the UniProt de novo AMP biosynthesis pathway annotation.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
AMP biosynthesis via de novo pathway; AMP
|
|
GO:0044209
AMP salvage
|
IEA
GO_REF:0000107 |
MARK AS OVER ANNOTATED |
Summary: ADSL produces AMP as part of DE NOVO purine synthesis (and the purine nucleotide cycle), not the salvage pathway. AMP salvage refers to recovery of AMP from adenine/adenosine via APRT and adenosine kinase, in which ADSL plays no part.
Reason: Misleading Ensembl-Compara ortholog IEA. ADSL's S-AMP-to-AMP reaction is de novo AMP biosynthesis, correctly captured by GO:0044208/GO:0006167; annotating it to AMP salvage misassigns the pathway context.
|
|
GO:0070626
(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation (ARBA/RHEA:23920) of the SAICAR-lyase activity, redundant with and corroborated by the human IDA and IBA annotations.
Reason: Correct core molecular function from the EC/Rhea mapping; matches the human experimental data (PMID:27590927).
Supporting Evidence:
PMID:19405474
the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate
|
|
GO:0097294
'de novo' XMP biosynthetic process
|
IEA
GO_REF:0000107 |
REMOVE |
Summary: XMP is synthesized from IMP by IMP dehydrogenase; ADSL is not involved in the XMP branch. This is an erroneous Ensembl-Compara ortholog transfer.
Reason: Biochemically incorrect. ADSL acts on the SAICAR-to-IMP and IMP-to-AMP branches, not on the IMP-to-XMP branch. No support for XMP biosynthesis.
|
|
GO:0005829
cytosol
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Immunofluorescence (HPA) localizes ADSL to the cytosol, consistent with the enzyme's cytosolic tetrameric active form.
Reason: Direct experimental (HPA immunofluorescence) evidence for cytosolic localization, concordant with IBA and Reactome TAS.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
|
|
GO:0004018
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
|
IDA
PMID:19405474 Biochemical and biophysical analysis of five disease-associa... |
ACCEPT |
Summary: Direct assay of the S-AMP-to-AMP + fumarate reaction on purified recombinant human ADSL and disease-associated mutants. Core molecular function.
Reason: Strong direct experimental evidence for the adenylosuccinate (S-AMP) lyase activity, measured continuously as SAMP is converted to AMP and fumarate.
Supporting Evidence:
PMID:19405474
as 60 ΞΌM SAMP is converted to AMP and fumarate
|
|
GO:0070626
(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
|
IDA
PMID:27590927 CRISPR-Cas9 induced mutations along de novo purine synthesis... |
ACCEPT |
Summary: SAICAR-lyase activity demonstrated in the context of de novo purine synthesis; CRISPR knockout of ADSL in HeLa cells leads to accumulation of its substrate, confirming the in vivo lyase step. Core molecular function.
Reason: Direct experimental evidence supporting the SAICAR-lyase activity; substrate accumulation on knockout confirms the enzyme performs this step in cells.
Supporting Evidence:
PMID:27590927
an accumulation of the substrate(s) for the knocked out enzyme was identified
|
|
GO:0032991
protein-containing complex
|
IDA
PMID:16973378 Expression, purification, and characterization of stable, re... |
KEEP AS NON CORE |
Summary: ADSL is a homotetramer, i.e. a protein-containing complex. Direct evidence from analytical ultracentrifugation of the purified recombinant enzyme (tetramer, ~220 kDa). Correct but very general.
Reason: The homotetrameric assembly is real and experimentally demonstrated, but "protein-containing complex" is an uninformative CC parent; the specific homotetramer state is better described in the SUBUNIT annotation. Retain as non-core.
Supporting Evidence:
PMID:16973378
the histidine-tagged enzyme is in tetrameric form with a molecular weight of 220 kDa
file:human/ADSL/ADSL-uniprot.txt
Homotetramer. Residues from neighboring subunits contribute catalytic and substrate-binding residues to each active site.
|
|
GO:0042802
identical protein binding
|
IDA
PMID:16973378 Expression, purification, and characterization of stable, re... |
KEEP AS NON CORE |
Summary: Self-association into a homotetramer is experimentally demonstrated (analytical ultracentrifugation). "Identical protein binding" is technically correct but uninformative relative to the catalytic MFs and the complex annotation.
Reason: Homo-oligomerization is real (homotetramer), so the term is not wrong, but per curation guidelines bare binding terms are non-core; the functionally informative annotations are the two lyase MFs and GO:0032991. Retain as non-core.
Supporting Evidence:
PMID:16973378
the histidine-tagged enzyme is in tetrameric form with a molecular weight of 220 kDa
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-73800 |
ACCEPT |
Summary: Reactome (SAICAR => AICAR + Fumarate) places ADSL in the cytosol; the active enzyme is a cytosolic tetramer. Concordant with IDA and IBA.
Reason: Traceable author statement supporting cytosolic localization, consistent with all other localization evidence.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-73828 |
ACCEPT |
Summary: Reactome (adenylosuccinate => AMP + fumarate) places ADSL in the cytosol; the active enzyme is a cytosolic tetramer.
Reason: Traceable author statement supporting cytosolic localization, consistent with all other localization evidence.
Supporting Evidence:
Reactome:R-HSA-73828
The active form of this enzyme is a cytosolic tetramer
|
|
GO:0006164
purine nucleotide biosynthetic process
|
IC
PMID:10888601 Human adenylosuccinate lyase (ADSL), cloning and characteriz... |
ACCEPT |
Summary: Curator inference (from the SAMP-lyase activity, GO:0004018) that ADSL is involved in purine nucleotide biosynthesis. Correct general biological process.
Reason: ADSL is a bifunctional enzyme of de novo purine synthesis and purine nucleotide recycling; the general purine nucleotide biosynthetic process term is appropriate.
Supporting Evidence:
PMID:10888601
Adenylosuccinate lyase (ADSL) is a bifunctional enzyme acting in de novo purine synthesis and purine nucleotide recycling
|
|
GO:0006167
AMP biosynthetic process
|
IDA
PMID:11428554 Determination, activity and biological role of adenylosuccin... |
ACCEPT |
Summary: ADSL activity measured in blood cells, with the study discussing its role in regulating cellular AMP levels. Supports involvement in AMP biosynthesis.
Reason: Direct measurement of ADSL activity and its role in cellular AMP regulation; consistent with the enzyme's S-AMP-to-AMP reaction in de novo AMP synthesis.
Supporting Evidence:
PMID:11428554
The biological role of adenylosuccinate lyase and its importance in regulating cellular levels of AMP is discussed
|
|
GO:0004018
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
|
IDA
PMID:16973378 Expression, purification, and characterization of stable, re... |
ACCEPT |
Summary: Recombinant human ADSL was characterized for its S-AMP lyase activity, with kinetic parameters (Vmax, Km) determined for S-AMP. Core molecular function.
Reason: Direct experimental characterization of the adenylosuccinate (S-AMP) lyase activity of purified human ADSL, defining EC 4.3.2.2 for the human enzyme.
Supporting Evidence:
PMID:16973378
The histidine-tagged and non-tagged adenylosuccinate lyases exhibit similar values of Vmax and Km for S-AMP
|
UniProtKB:P30566 (PUR8_HUMAN). HGNC:291. EC 4.3.2.2. Chromosome 22q13.1.
Lyase 1 family, adenylosuccinate lyase subfamily.
Deep research status: falcon provider out of credits (HTTP 402); no
-deep-research-falcon.md generated. Review grounded in the cached UniProt
record, the seeded GOA, cached publications (PMID_10888601, 11428554, 16973378,
19405474, 27590927), and the two cached Reactome entries. PMID:19405474 is the
only one with full text available in the cache; the others are abstract-only.
ADSL is a homotetrameric cytosolic enzyme that catalyses two distinct
beta-elimination (fumarate-releasing) reactions in purine metabolism, both in
the same active site (three subunits contribute residues to each of the four
active sites):
Both activities reside at the same active site; a single competitive inhibitor
(APBADP) blocks both, showing the two substrates occupy the same site
[PMID:19405474 full text].
Key verbatim support:
- UniProt FUNCTION: "Catalyzes two non-sequential steps in de novo AMP synthesis"
and "converts succinyladenosine monophosphate (SAMP) to AMP and fumarate."
- PMID:19405474: "Adenylosuccinate lyase (EC 4.3.2.2) catalyzes two Ξ²-elimination
reactions in the de novo synthesis of purines: the cleavage of adenylosuccinate
(SAMP)1 to AMP and fumarate; and the conversion of 5-aminoimidazole-4-
(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-
carboxamide ribonucleotide (AICAR) and fumarate."
- PMID:19405474: "ASL, a catalyst of key reactions in purine biosynthesis, is
normally a homotetramer in which three subunits contribute to each of four
active sites."
- Reactome R-HSA-73800 / R-HSA-73828: "The active form of this enzyme is a
cytosolic tetramer" and it mediates both reactions in vivo.
Cytosol. IDA (HPA immunofluorescence, GO_REF:0000052), TAS (Reactome), IBA. Also
reported to associate with the purinosome (multi-enzyme DNPS complex) under some
metabolic conditions [Reactome R-HSA-73800; PMID:27590927].
Adenylosuccinate lyase deficiency (ADSLD; MIM:103050), autosomal recessive.
Accumulation of dephosphorylated substrates SAICA-riboside (SAICAr) and
succinyladenosine (S-Ado); psychomotor/mental retardation, epilepsy, autistic
features. S-Ado/SAICAr ratio in CSF correlates with severity PMID:10888601.
Many characterised missense variants reduce activity (PMID:19405474 etc).
MF (core):
- GO:0004018 SAMP lyase β IDA x3 (PMID:19405474, 16973378) + IBA + IEA β ACCEPT (core).
- GO:0070626 SAICAR lyase β IDA (PMID:27590927) + IBA + IEA β ACCEPT (core).
- GO:0003824 catalytic activity (IEA/InterPro) β too general; MARK_AS_OVER_ANNOTATED
(parent of the two specific MFs already present).
- GO:0042802 identical protein binding (IDA PMID:16973378; IEA) β homotetramer, so
self-association is real, but bare-binding term is uninformative vs the enzymatic
MFs and complex CC β KEEP_AS_NON_CORE (IDA), IEA duplicate KEEP_AS_NON_CORE.
CC (core = cytosol):
- GO:0005829 cytosol β IDA/TAS/IBA β ACCEPT.
- GO:0032991 protein-containing complex (IDA PMID:16973378) β homotetramer =
protein-containing complex; correct but very general β KEEP_AS_NON_CORE.
BP:
- GO:0006189 'de novo' IMP biosynthetic process (IEA) β ACCEPT core (SAICARβAICAR
is step 2/2 of the IMP de novo pathway; UniProt PATHWAY).
- GO:0044208 'de novo' AMP biosynthetic process (IBA + IEA) β ACCEPT core (SAMPβAMP
is AMP-from-IMP step 2/2; UniProt PATHWAY).
- GO:0006164 purine nucleotide biosynthetic process (IC PMID:10888601) β ACCEPT
(correct, general parent).
- GO:0006167 AMP biosynthetic process (IDA PMID:11428554; IEA) β ACCEPT/KEEP; the
IDA in blood cells measures AMP-producing activity.
- GO:0009152 purine ribonucleotide biosynthetic process (IEA InterPro) β ACCEPT
(correct general parent).
- GO:0044209 AMP salvage (IEA Ensembl, GO_REF:0000107) β MISLEADING. ADSL's AMP
production (SAMPβAMP) is part of DE NOVO synthesis (and the purine nucleotide
cycle), not the salvage (hypoxanthine/adenine phosphoribosyltransferase) pathway.
β MARK_AS_OVER_ANNOTATED (Ensembl ortholog electronic transfer, biologically off).
- GO:0006177 GMP biosynthetic process (IEA Ensembl) β REMOVE. GMP is made from IMP
by IMPDH + GMPS; ADSL is not on the GMP branch. Wrong IEA ortholog transfer.
- GO:0097294 'de novo' XMP biosynthetic process (IEA Ensembl) β REMOVE. XMP is made
from IMP by IMPDH; ADSL not involved. Wrong IEA ortholog transfer.
- GO:0009060 aerobic respiration (IEA Ensembl) β REMOVE. ADSL is a cytosolic purine
biosynthesis enzyme; fumarate release is not participation in aerobic respiration.
Over-propagated ortholog IEA.
- GO:0001666 response to hypoxia (IEA Ensembl) β REMOVE. No evidence ADSL itself is
a hypoxia-response effector; electronic ortholog transfer, not supportable.
- GO:0007584 response to nutrient (IEA Ensembl) β REMOVE. Electronic ortholog
transfer; not supportable for human ADSL.
- GO:0042594 response to starvation (IEA Ensembl) β REMOVE. Same.
- GO:0014850 response to muscle activity (IEA Ensembl) β REMOVE. ADSL is highly
expressed in muscle and participates in the purine nucleotide cycle there, but
"response to muscle activity" (a stimulus-response BP) is not a supportable
molecular role for ADSL from an electronic ortholog transfer. Over-propagation.
The GO_REF:0000107 (Ensembl Compara) block of stimulus/response and off-pathway
biosynthesis terms is the classic over-propagation cluster and is treated as such.
id: P30566
gene_symbol: ADSL
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: Adenylosuccinate lyase (ADSL; adenylosuccinase; EC 4.3.2.2) is a cytosolic
homotetrameric enzyme of purine metabolism that catalyses two distinct beta-elimination
(fumarate-releasing) reactions in the same active site. In de novo purine synthesis
it cleaves SAICAR ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate)
to AICAR plus fumarate, completing the step 2/2 that converts SAICAR toward IMP;
and at the IMP-to-AMP branch it cleaves adenylosuccinate (S-AMP) to AMP plus fumarate.
The enzyme therefore contributes to both de novo IMP biosynthesis and de novo AMP
biosynthesis. It assembles as a homotetramer in which three subunits contribute
residues to each of the four active sites, and can associate with other de novo
purine synthesis enzymes in the purinosome. Loss-of-function variants cause adenylosuccinate
lyase deficiency (ADSLD), an autosomal-recessive neurodevelopmental disorder marked
by psychomotor/mental retardation, epilepsy and autistic features, with accumulation
of the dephosphorylated substrates SAICA-riboside and succinyladenosine in body
fluids.
alternative_products:
- name: '1'
id: P30566-1
- name: 2 (Delta-ADSL)
id: P30566-2
sequence_note: VSP_000318
existing_annotations:
- term:
id: GO:0070626
label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
lyase (fumarate-forming) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: SAICAR-lyase (fumarate-forming) activity, one of the two core catalytic
functions of ADSL. This IBA is fully consistent with the human experimental
data and the enzyme's role in de novo IMP synthesis.
action: ACCEPT
reason: This is a core molecular function of ADSL, cleaving SAICAR to AICAR plus
fumarate as step 2/2 of the de novo IMP pathway. The phylogenetic inference
matches the human IDA (PMID:27590927) and UniProt.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
- reference_id: PMID:19405474
supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR) and fumarate
- term:
id: GO:0004018
label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Adenylosuccinate (S-AMP) lyase (fumarate-forming) activity, the second
core catalytic function of ADSL, cleaving S-AMP to AMP plus fumarate at the
IMP-to-AMP branch.
action: ACCEPT
reason: Core molecular function, corroborated by human IDA data (PMID:19405474,
PMID:16973378) and UniProt catalytic-activity annotation (EC 4.3.2.2, Rhea RHEA:16853).
supported_by:
- reference_id: PMID:19405474
supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: ADSL is a cytosolic enzyme; its active form is a cytosolic tetramer.
This localization is supported by IBA, IDA (HPA) and TAS (Reactome).
action: ACCEPT
reason: Cytosolic localization is well established and consistent across phylogenetic,
immunofluorescence and Reactome evidence.
supported_by:
- reference_id: Reactome:R-HSA-73800
supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
id: GO:0044208
label: '''de novo'' AMP biosynthetic process'
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: ADSL catalyses the final step (S-AMP to AMP) of de novo AMP biosynthesis
from IMP. This is a core biological process for the gene.
action: ACCEPT
reason: The SAMP-to-AMP reaction is AMP-from-IMP step 2/2 of the de novo AMP pathway,
as stated in the UniProt PATHWAY annotation. IBA is at the correct level.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: 'AMP biosynthesis via de novo pathway; AMP'
- term:
id: GO:0003824
label: catalytic activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: Root-level catalytic activity term from InterPro2GO. Not wrong, but far
too general given the two specific lyase activities (GO:0004018, GO:0070626)
are already annotated with experimental evidence.
action: MARK_AS_OVER_ANNOTATED
reason: This is an uninformative parent of the specific molecular functions ADSL
is already annotated to. It adds no information beyond the specific lyase terms.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
- term:
id: GO:0004018
label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Electronic annotation (ARBA/RHEA:16853) of the S-AMP lyase activity,
redundant with and corroborated by the experimental IDA annotations.
action: ACCEPT
reason: Correct molecular function derived from the EC/Rhea mapping; matches the
human experimental data.
supported_by:
- reference_id: PMID:19405474
supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
id: GO:0009152
label: purine ribonucleotide biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: General purine ribonucleotide biosynthesis process, correctly capturing
ADSL's role in de novo IMP/AMP synthesis, though broader than the specific de
novo terms.
action: ACCEPT
reason: A correct, if general, biological-process parent. ADSL participates in
purine ribonucleotide biosynthesis via de novo IMP and AMP synthesis.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
- term:
id: GO:0001666
label: response to hypoxia
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Stimulus-response process transferred electronically from a rat ortholog
via Ensembl Compara. There is no evidence that human ADSL functions as an effector
in the hypoxia response; this is an over-propagated ortholog IEA.
action: REMOVE
reason: ADSL is a cytosolic purine-biosynthesis lyase. "Response to hypoxia" is
a stimulus-response biological process not supported by any experimental data
for ADSL, and is a classic Ensembl-Compara over-propagation from an ortholog.
- term:
id: GO:0006167
label: AMP biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: AMP biosynthetic process (general parent of de novo AMP biosynthesis),
correctly capturing ADSL's production of AMP from S-AMP.
action: ACCEPT
reason: ADSL produces AMP as the second step of AMP-from-IMP; this general term
is correct and is also supported by the human IDA (PMID:11428554).
supported_by:
- reference_id: PMID:19405474
supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
id: GO:0006177
label: GMP biosynthetic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: GMP biosynthesis is not catalysed or supported by ADSL. GMP is produced
from IMP by IMP dehydrogenase and GMP synthase; ADSL acts on the AMP branch,
not the GMP branch.
action: REMOVE
reason: Biochemically incorrect. ADSL has no role in GMP synthesis; this is an
erroneous Ensembl-Compara ortholog transfer. The enzyme's reactions (SAICAR
to AICAR, and S-AMP to AMP) lie on the IMP and AMP branches only.
- term:
id: GO:0006189
label: '''de novo'' IMP biosynthetic process'
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: ADSL contributes to de novo IMP biosynthesis via its SAICAR-lyase step
(SAICAR to AICAR + fumarate), which is step 2/2 in the conversion of SAICAR
toward IMP. Core biological process.
action: ACCEPT
reason: Correct core process. The UniProt PATHWAY annotation places this SAICAR-lyase
reaction within de novo IMP biosynthesis.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: 'IMP biosynthesis via de novo pathway'
- term:
id: GO:0007584
label: response to nutrient
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Stimulus-response process transferred electronically from a rat ortholog.
No experimental support for human ADSL acting as a nutrient-response effector.
action: REMOVE
reason: Over-propagated Ensembl-Compara ortholog IEA; not a supportable molecular
role for human ADSL, which is a constitutive purine-biosynthesis enzyme.
- term:
id: GO:0009060
label: aerobic respiration
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Aerobic respiration is a mitochondrial process; ADSL is a cytosolic purine-biosynthesis
lyase. Fumarate release by ADSL does not constitute participation in aerobic
respiration.
action: REMOVE
reason: Biologically incorrect over-propagation via Ensembl Compara. ADSL is not
part of the respiratory chain or TCA cycle; its product fumarate feeds general
metabolism but that does not make ADSL a participant in aerobic respiration.
- term:
id: GO:0014850
label: response to muscle activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Although ADSL is highly expressed in skeletal muscle and participates
in the purine nucleotide cycle there, "response to muscle activity" is a stimulus-response
biological process electronically transferred from a rat ortholog, without experimental
support for human ADSL as an effector of this response.
action: REMOVE
reason: Over-propagated Ensembl-Compara ortholog IEA. Muscle expression does not
justify a stimulus-response BP annotation; ADSL's role in muscle is its constitutive
purine-cycle catalysis.
- term:
id: GO:0042594
label: response to starvation
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Stimulus-response process transferred electronically from a rat ortholog.
No experimental support for human ADSL as a starvation-response effector.
action: REMOVE
reason: Over-propagated Ensembl-Compara ortholog IEA, not supportable for human
ADSL.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: enables
review:
summary: Self-association is real (ADSL is a homotetramer), but "identical protein
binding" is an uninformative molecular-function term compared with the enzyme's
catalytic activities and its "protein-containing complex" annotation. This IEA
duplicates the IDA below.
action: KEEP_AS_NON_CORE
reason: The homotetrameric assembly makes identical-protein binding technically
correct, but it is non-core relative to the catalytic MFs. Retain as non-core;
the homotetramer is better captured by GO:0032991 and the SUBUNIT annotation.
supported_by:
- reference_id: PMID:19405474
supporting_text: ASL, a catalyst of key reactions in purine biosynthesis, is
normally a homotetramer in which three subunits contribute to each of four
active sites
- term:
id: GO:0044208
label: '''de novo'' AMP biosynthetic process'
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Electronic annotation of de novo AMP biosynthesis (UniPathway UPA00075),
redundant with the IBA and consistent with the S-AMP-to-AMP reaction.
action: ACCEPT
reason: Correct core process, matching the UniProt de novo AMP biosynthesis pathway
annotation.
supported_by:
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: 'AMP biosynthesis via de novo pathway; AMP'
- term:
id: GO:0044209
label: AMP salvage
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: ADSL produces AMP as part of DE NOVO purine synthesis (and the purine
nucleotide cycle), not the salvage pathway. AMP salvage refers to recovery of
AMP from adenine/adenosine via APRT and adenosine kinase, in which ADSL plays
no part.
action: MARK_AS_OVER_ANNOTATED
reason: Misleading Ensembl-Compara ortholog IEA. ADSL's S-AMP-to-AMP reaction
is de novo AMP biosynthesis, correctly captured by GO:0044208/GO:0006167; annotating
it to AMP salvage misassigns the pathway context.
- term:
id: GO:0070626
label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
lyase (fumarate-forming) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Electronic annotation (ARBA/RHEA:23920) of the SAICAR-lyase activity,
redundant with and corroborated by the human IDA and IBA annotations.
action: ACCEPT
reason: Correct core molecular function from the EC/Rhea mapping; matches the human
experimental data (PMID:27590927).
supported_by:
- reference_id: PMID:19405474
supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR) and fumarate
- term:
id: GO:0097294
label: '''de novo'' XMP biosynthetic process'
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: XMP is synthesized from IMP by IMP dehydrogenase; ADSL is not involved
in the XMP branch. This is an erroneous Ensembl-Compara ortholog transfer.
action: REMOVE
reason: Biochemically incorrect. ADSL acts on the SAICAR-to-IMP and IMP-to-AMP
branches, not on the IMP-to-XMP branch. No support for XMP biosynthesis.
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: Immunofluorescence (HPA) localizes ADSL to the cytosol, consistent with
the enzyme's cytosolic tetrameric active form.
action: ACCEPT
reason: Direct experimental (HPA immunofluorescence) evidence for cytosolic localization,
concordant with IBA and Reactome TAS.
supported_by:
- reference_id: Reactome:R-HSA-73800
supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
id: GO:0004018
label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
evidence_type: IDA
original_reference_id: PMID:19405474
qualifier: enables
review:
summary: Direct assay of the S-AMP-to-AMP + fumarate reaction on purified recombinant
human ADSL and disease-associated mutants. Core molecular function.
action: ACCEPT
reason: Strong direct experimental evidence for the adenylosuccinate (S-AMP) lyase
activity, measured continuously as SAMP is converted to AMP and fumarate.
supported_by:
- reference_id: PMID:19405474
supporting_text: as 60 ΞΌM SAMP is converted to AMP and fumarate
- term:
id: GO:0070626
label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
lyase (fumarate-forming) activity
evidence_type: IDA
original_reference_id: PMID:27590927
qualifier: enables
review:
summary: SAICAR-lyase activity demonstrated in the context of de novo purine synthesis;
CRISPR knockout of ADSL in HeLa cells leads to accumulation of its substrate,
confirming the in vivo lyase step. Core molecular function.
action: ACCEPT
reason: Direct experimental evidence supporting the SAICAR-lyase activity; substrate
accumulation on knockout confirms the enzyme performs this step in cells.
supported_by:
- reference_id: PMID:27590927
supporting_text: an accumulation of the substrate(s) for the knocked out enzyme
was identified
- term:
id: GO:0032991
label: protein-containing complex
evidence_type: IDA
original_reference_id: PMID:16973378
qualifier: part_of
review:
summary: ADSL is a homotetramer, i.e. a protein-containing complex. Direct evidence
from analytical ultracentrifugation of the purified recombinant enzyme (tetramer,
~220 kDa). Correct but very general.
action: KEEP_AS_NON_CORE
reason: The homotetrameric assembly is real and experimentally demonstrated, but
"protein-containing complex" is an uninformative CC parent; the specific homotetramer
state is better described in the SUBUNIT annotation. Retain as non-core.
supported_by:
- reference_id: PMID:16973378
supporting_text: the histidine-tagged enzyme is in tetrameric form with a molecular
weight of 220 kDa
- reference_id: file:human/ADSL/ADSL-uniprot.txt
supporting_text: Homotetramer. Residues from neighboring subunits contribute
catalytic and substrate-binding residues to each active site.
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IDA
original_reference_id: PMID:16973378
qualifier: enables
review:
summary: Self-association into a homotetramer is experimentally demonstrated (analytical
ultracentrifugation). "Identical protein binding" is technically correct but
uninformative relative to the catalytic MFs and the complex annotation.
action: KEEP_AS_NON_CORE
reason: Homo-oligomerization is real (homotetramer), so the term is not wrong,
but per curation guidelines bare binding terms are non-core; the functionally
informative annotations are the two lyase MFs and GO:0032991. Retain as non-core.
supported_by:
- reference_id: PMID:16973378
supporting_text: the histidine-tagged enzyme is in tetrameric form with a molecular
weight of 220 kDa
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-73800
qualifier: located_in
review:
summary: Reactome (SAICAR => AICAR + Fumarate) places ADSL in the cytosol; the
active enzyme is a cytosolic tetramer. Concordant with IDA and IBA.
action: ACCEPT
reason: Traceable author statement supporting cytosolic localization, consistent
with all other localization evidence.
supported_by:
- reference_id: Reactome:R-HSA-73800
supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-73828
qualifier: located_in
review:
summary: Reactome (adenylosuccinate => AMP + fumarate) places ADSL in the cytosol;
the active enzyme is a cytosolic tetramer.
action: ACCEPT
reason: Traceable author statement supporting cytosolic localization, consistent
with all other localization evidence.
supported_by:
- reference_id: Reactome:R-HSA-73828
supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
id: GO:0006164
label: purine nucleotide biosynthetic process
evidence_type: IC
original_reference_id: PMID:10888601
qualifier: involved_in
review:
summary: Curator inference (from the SAMP-lyase activity, GO:0004018) that ADSL
is involved in purine nucleotide biosynthesis. Correct general biological process.
action: ACCEPT
reason: ADSL is a bifunctional enzyme of de novo purine synthesis and purine nucleotide
recycling; the general purine nucleotide biosynthetic process term is appropriate.
supported_by:
- reference_id: PMID:10888601
supporting_text: Adenylosuccinate lyase (ADSL) is a bifunctional enzyme acting
in de novo purine synthesis and purine nucleotide recycling
- term:
id: GO:0006167
label: AMP biosynthetic process
evidence_type: IDA
original_reference_id: PMID:11428554
qualifier: involved_in
review:
summary: ADSL activity measured in blood cells, with the study discussing its
role in regulating cellular AMP levels. Supports involvement in AMP biosynthesis.
action: ACCEPT
reason: Direct measurement of ADSL activity and its role in cellular AMP regulation;
consistent with the enzyme's S-AMP-to-AMP reaction in de novo AMP synthesis.
supported_by:
- reference_id: PMID:11428554
supporting_text: The biological role of adenylosuccinate lyase and its importance
in regulating cellular levels of AMP is discussed
- term:
id: GO:0004018
label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
evidence_type: IDA
original_reference_id: PMID:16973378
qualifier: enables
review:
summary: Recombinant human ADSL was characterized for its S-AMP lyase activity,
with kinetic parameters (Vmax, Km) determined for S-AMP. Core molecular function.
action: ACCEPT
reason: Direct experimental characterization of the adenylosuccinate (S-AMP) lyase
activity of purified human ADSL, defining EC 4.3.2.2 for the human enzyme.
supported_by:
- reference_id: PMID:16973378
supporting_text: The histidine-tagged and non-tagged adenylosuccinate lyases
exhibit similar values of Vmax and Km for S-AMP
core_functions:
- description: Adenylosuccinate (S-AMP) lyase activity - cleaves N6-(1,2-dicarboxyethyl)-AMP
(S-AMP) to AMP and fumarate, the second step of de novo AMP biosynthesis from
IMP.
molecular_function:
id: GO:0004018
label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
directly_involved_in:
- id: GO:0044208
label: '''de novo'' AMP biosynthetic process'
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:19405474
supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- reference_id: PMID:16973378
supporting_text: The histidine-tagged and non-tagged adenylosuccinate lyases exhibit
similar values of Vmax and Km for S-AMP
- description: SAICAR-lyase activity - cleaves SAICAR to AICAR and fumarate, step 2/2
of de novo IMP biosynthesis, contributing to purine nucleotide biosynthesis.
molecular_function:
id: GO:0070626
label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
lyase (fumarate-forming) activity
directly_involved_in:
- id: GO:0006189
label: '''de novo'' IMP biosynthetic process'
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:19405474
supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)
and fumarate
- reference_id: PMID:27590927
supporting_text: an accumulation of the substrate(s) for the knocked out enzyme
was identified
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
reference_review:
relevance: LOW
correctness: UNVERIFIED
review_notes: Source of a block of stimulus-response and off-pathway biosynthesis
IEAs (hypoxia, nutrient, starvation, muscle activity, aerobic respiration, GMP,
XMP, AMP salvage) transferred from rodent orthologs. Several are biologically
unsupportable for human ADSL and are flagged for REMOVE / MARK_AS_OVER_ANNOTATED.
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10888601
title: Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length
cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in
six patients.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes ADSL as a bifunctional de novo purine synthesis/recycling
enzyme, characterizes the enzymatically inactive isoform 2, and defines the
molecular basis of ADSL deficiency in six patients (abstract verified against
cached record).
- id: PMID:11428554
title: Determination, activity and biological role of adenylosuccinate lyase in
blood cells.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Measures ADSL activity in human blood cells and discusses its role
in regulating cellular AMP levels; supports the AMP biosynthetic process annotation.
- id: PMID:16973378
title: Expression, purification, and characterization of stable, recombinant human
adenylosuccinate lyase.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Defines the recombinant human enzyme's S-AMP lyase kinetics (Vmax/Km)
and demonstrates the homotetramer (~220 kDa) by analytical ultracentrifugation;
basis for the MF, identical-protein-binding, and protein-complex annotations.
- id: PMID:19405474
title: Biochemical and biophysical analysis of five disease-associated human adenylosuccinate
lyase mutants.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full text available; explicitly states the two beta-elimination
reactions (SAMP->AMP+fumarate; SAICAR->AICAR+fumarate) and the homotetramer
with three subunits per active site. Primary support for both core MFs.
- id: PMID:27590927
title: CRISPR-Cas9 induced mutations along de novo purine synthesis in HeLa cells
result in accumulation of individual enzyme substrates and affect purinosome formation.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: CRISPR knockout of de novo purine synthesis enzymes (including ADSL)
in HeLa cells causes accumulation of the knocked-out enzyme's substrate and
impairs purinosome assembly; supports the in vivo SAICAR-lyase step.
- id: Reactome:R-HSA-73800
title: SAICAR => AICAR + Fumarate
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction for the SAICAR-lyase step; states the active enzyme
is a cytosolic tetramer and mediates both reactions in vivo.
- id: Reactome:R-HSA-73828
title: adenylosuccinate => adenosine 5'-monophosphate + fumarate
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction for the S-AMP lyase step; states the active enzyme
is a cytosolic tetramer.
- id: file:human/ADSL/ADSL-uniprot.txt
title: UniProtKB P30566 (PUR8_HUMAN) adenylosuccinate lyase record
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Curated UniProt record; source of the dual catalytic-activity, de
novo IMP/AMP pathway, homotetramer subunit, and ADSLD disease annotations.